The Next Ozempic? This Unapproved Peptide Comes With a Big Catch
ScienceAlert • • health
Key Points:
- Retatrutide is an experimental injectable peptide under clinical trials that targets three hormone pathways to reduce appetite and influence metabolism, showing potential for significant weight loss surpassing drugs like Ozempic and Wegovy.
- Despite promising trial results, retatrutide remains unapproved globally but is already available illicitly online, raising safety concerns due to lack of regulation and potential contamination or incorrect dosing.
- Gym-goers are attracted to retatrutide for rapid fat loss and a leaner appearance, but rapid weight loss may also reduce muscle mass and impact psychological well-being, including mood and social relationships.
- Common side effects include gastrointestinal issues such as nausea, vomiting, and diarrhea, with at least one reported death under investigation; authorities warn against using unapproved peptide products.
- Research suggests retatrutide may influence brain pathways related to reward, motivation, and sexual drive, potentially causing emotional detachment or changes in personal relationships.
